Related Experiment Video
Updated: Feb 19, 2026
18:46
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
13.7K
Developing pharmacy research while advancing pharmacy education and practice in Malawi
Hanna Stambuli-Kumwenda1, Nelson Nyoloka2, Hope Michael Chadwala3
1University of North Carolina Project, Tidziwe Centre Private Bag A-104 Lilongwe, Malawi.
The International Journal of Pharmacy Practice
|February 17, 2026
Summary
Current pharmacy education and practice in Malawi are advancing, with pharmacists actively engaged in research. Future advancements in education are expected to enhance clinical practice and expand research into implementation science, population health, and health outcomes.
Area of Science:
- Pharmacy Education and Practice
- Pharmaceutical Research
- Health Sciences in Malawi
Background:
- Overview of current pharmacy education and practice landscape in Malawi.
- Identification of existing research activities undertaken by pharmacists.
Purpose of the Study:
- To describe current pharmacy education, practice, and research in Malawi.
- To comment on ongoing advancements and their implications.
Main Methods:
- Literature review and synthesis of current data on pharmacy in Malawi.
- Analysis of research endeavors and educational progress.
Main Results:
- Pharmacists in Malawi are involved in diverse research, including antimicrobial stewardship, clinical trials, and medication use processes.
- Advancements in pharmacy education are poised to improve clinical practice and pharmaceutical care.
- Anticipated expansion of research opportunities in implementation science, population health, and health outcomes.
Conclusions:
- Pharmacy education advancements in Malawi will drive progress in clinical practice and pharmaceutical care.
- Future research will likely focus on implementation science, population health, and health outcomes, further strengthening the profession.
Related Concept Videos
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:29Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
01:26Pharmaceutical Poisoning: Potential Scenarios
19
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
19
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
22
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
22
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
229
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
229
01:26Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K